These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11994044)

  • 1. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden.
    Agréus L; Borgquist L
    Pharmacoeconomics; 2002; 20(5):347-55. PubMed ID: 11994044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of acid-related disorders to a health maintenance organization.
    Levin TR; Schmittdiel JA; Kunz K; Henning JM; Henke CJ; Colby CJ; Selby JV
    Am J Med; 1997 Dec; 103(6):520-8. PubMed ID: 9428836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
    Bursey F; Crowley M; Janes C; Turner CJ
    CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization.
    Henke CJ; Levin TR; Henning JM; Potter LP
    Am J Gastroenterol; 2000 Mar; 95(3):788-92. PubMed ID: 10710076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
    Myrvold HE; Lundell L; Miettinen P; Pedersen SA; Liedman B; Hatlebakk J; Julkunen R; Levander K; Lamm M; Mattson C; Carlsson J; Ståhlhammar NO;
    Gut; 2001 Oct; 49(4):488-94. PubMed ID: 11559644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
    Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
    Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study.
    Moghimi-Dehkordi B; Vahedi M; Khoshkrood Mansoori B; Kasaeian A; Safaee A; Habibi M; Pourhoseingholi A; Pourhoseingholi MA; Zali MR
    Arab J Gastroenterol; 2011 Jun; 12(2):86-9. PubMed ID: 21684479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacoeconomics of dyspesia and peptic ulcer disease].
    Kusowska J
    Pol Merkur Lekarski; 2006 Jan; 20(115):125-8. PubMed ID: 16617753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: gastro-oesophageal reflux disease--the health economic implications.
    Mason J; Hungin AP
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():20-31. PubMed ID: 16042656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zero inflated statistical count models for analysing the costs imposed by GERD and dyspepsia.
    Akbarzadeh Baghban A; Pourhoseingholi A; Zayeri F; Ashtari S; Zali MR
    Arab J Gastroenterol; 2013 Dec; 14(4):165-8. PubMed ID: 24433646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic acid-related disorders are common and underinvestigated.
    Majumdar SR; Soumerai SB; Farraye FA; Lee M; Kemp JA; Henning JM; Schrammel P; LeCates RF; Ross-Degnan D
    Am J Gastroenterol; 2003 Nov; 98(11):2409-14. PubMed ID: 14638341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both?
    Quigley EM
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S13-8. PubMed ID: 11430503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-oesophageal reflux disease and ulcer disease.
    Mahmood Z; McNamara D
    Aliment Pharmacol Ther; 2003 Nov; 18 Suppl 3():31-7. PubMed ID: 14531738
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
    Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE
    Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyspepsia, heartburn, and peptic ulcer disease in veterans.
    Dominitz JA; Provenzale D
    Am J Gastroenterol; 1999 Aug; 94(8):2086-93. PubMed ID: 10445532
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.